Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
abbvie
abbvie
Page 3 of 3
Health
Drug companies are paying huge sums to fast-track FDA approval
By
Laura Lorenzetti
October 20, 2015
Features
ISIS and drug sales — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
July 24, 2015
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By
Tom Huddleston Jr.
July 7, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Finance
Corporate tax dodgers might make Congress actually do something
By
Tory Newmyer
July 22, 2014
Finance
Markets end week with a rally, despite geopolitical turmoil
By
Tom Huddleston Jr.
July 18, 2014
Most Popular
Future of Work
Ford CEO says he has 5,000 open mechanic jobs with 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Innovation
Ford CEO says a 'shocking' discovery after taking apart rival Tesla and Chinese EVs led to a 'brutal' business decision
By
Marco Quiroz-Gutierrez
AI
The rise of Yann LeCun, the 65-year-old NYU professor who is planning to leave Mark Zuckerberg's highly paid team at...
By
Dave Smith